))
Episode 2: Pressors
Manage episode 407249559 series 3559098
Contenuto fornito da Barrett Bowen and No Shock Advised Podcast. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Barrett Bowen and No Shock Advised Podcast o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Welcome to the No Shock Advised Podcast with Brett and Matt.
This week: We’re discussing vasopressors (and inodilators): the what, the where, and the why. There’s a lot of ground to cover, so buckle up.
We have a form for asking questions here.
You can check us out on Facebook here.
You can email us @ NoShockAdvisedPodcast@gmail.com.
If you feel led, you can access our Patreon here.
References and Further Readings:
- Ninja Nerd: Vasopressors
- emDOCs: Evidence Based Approach to Pressors in Shock
- Resus: Cardiogenic Shock: Which Vasopressor to Use
- Relias Media: The Use of Vasopressors and Inotropes in the Emergency Department for the Treatment of Shock
- Levy, 2020: Vasopressor Use in Cardiogenic Shock
- Levy, 2019: Inotropes and Vasopressors Use in Cardiogenic Shock: When, Which, and How Much?
- Yue, 2019: Vasopressor Support in Managing Acute Spinal Cord Injury: Current Knowledge
- Ploumis, 2010: A systematic Review of the Evidence Supporting a Role for Vasopressor Support in Acute SCI
- Sedhai, 2022: Vasopressin Versus Norepinephrine as the First-Line Vasopressor in Septic Shock
- Kubena, 2022: Push-Dose Vasopressors in the Emergency Department
- Zotzmann, 2022: Obstructive Shock from Diagnosis to Treatment
- Ammar, 2022: Timing of Vasoactive Agents and Corticosteroid Initiation ins Septic Shock
- Sahoo, 2022: Comparison of Norepinephrine and Terlipressin vs Norepinephrine Alone for Management of Septic Shock
6 episodi
Condividi
